药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Zuclopenthixol
Mitazalimab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Mitazalimab.
Zuclopenthixol
Suvratoxumab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Suvratoxumab.
Zuclopenthixol
Asunercept
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Asunercept.
Zuclopenthixol
Ponezumab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Ponezumab.
Zuclopenthixol
Zolbetuximab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Zolbetuximab.
Zuclopenthixol
Utomilumab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Utomilumab.
Zuclopenthixol
Telisotuzumab vedotin
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Telisotuzumab vedotin.
Zuclopenthixol
Tigatuzumab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Tigatuzumab.
Zuclopenthixol
Tezepelumab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Tezepelumab.
Zuclopenthixol
Frovocimab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Frovocimab.
Zuclopenthixol
Abrilumab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Abrilumab.
Zuclopenthixol
Ipafricept
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Ipafricept.
Zuclopenthixol
Tafasitamab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Tafasitamab.
Zuclopenthixol
Apomab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Apomab.
Zuclopenthixol
Gremubamab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Gremubamab.
Zuclopenthixol
Pateclizumab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Pateclizumab.
Zuclopenthixol
Dalantercept
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Dalantercept.
Zuclopenthixol
Margetuximab
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Margetuximab.
Zuclopenthixol
Opicinumab
The risk or severity of adverse effects can be increased when Opicinumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Pamrevlumab
The risk or severity of adverse effects can be increased when Pamrevlumab is combined with Trastuzumab deruxtecan.